2,440 results match your criteria: "Bordeaux University Hospital.[Affiliation]"
Eval Program Plann
February 2025
Bordeaux Population Health Research Center U 1219, Inserm - University of Bordeaux, Case 11, 146 rue Léon Saignat, Bordeaux Cedexx 33076, France; Bordeaux University Hospital -Saint-André Hospital, 1 rue Jean Burguet, Bordeaux 33000, France. Electronic address:
Objective: The concept of viable validity was first defined in 2010 within the framework of the integrative validity model. The concept has continued to evolve in the intervening years, and the purpose of this systematic scoping review is to describe and analyze the ways in which it has been deployed and appropriated by various research traditions.
Methods: We began by including all articles which cite Chen's original article "The bottom-up approach to integrative validity: a new perspective for program evaluation (Eval Program Plann.
J Hosp Infect
November 2024
HydroSciences Montpellier, IRD, CNRS, Montpellier University, Hospital Hygiene and Infection Control Department, University Hospital of Montpellier, Montpellier, France.
Arthritis Care Res (Hoboken)
November 2024
Geneva University Hospitals, Geneva, Switzerland.
Am J Transplant
November 2024
Department of Pediatric Nephrology and Transplantation, Children's Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Neurocrit Care
November 2024
Anesthesiology and Critical Care Department, Bordeaux University Hospital, 33 000, Bordeaux, France.
Nat Commun
November 2024
The Hospital for Sick Children, Toronto, Ontario, Canada.
Arthritis Res Ther
October 2024
Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Objective: Patients with diffuse cutaneous systemic sclerosis (dcSSc) frequently show spontaneous improvement of skin fibrosis. Our aim was to examine whether an improvement in skin fibrosis predicts lower likelihood of visceral organ progression and better survival.
Methods: Patients from the European Scleroderma Trials and Research (EUSTAR) cohort with dcSSc, baseline modified Rodnan skin score (mRSS) ≥7, and valid mRSS at 12±3 months follow up were included.
J Hum Hypertens
January 2025
Coronary and vascular diseases Department, Bordeaux university Hospital, Bordeaux, France.
Malignant hypertension (MHT) crisis triggers widespread microvascular damage, particularly in the brain. Despite recent MRI evidence highlighting acute cerebral injuries during MHT crises, follow-up data remain scarce. This study seeks to fill this gap by exploring how brain MRI markers evolve following acute MHT crisis management.
View Article and Find Full Text PDFBlood
November 2024
Hopital Trousseau, Paris, France.
Perfusion
November 2024
Department of Cardiovascular Anesthesia and Critical Care, CHU Bordeaux, Bordeaux, France.
Introduction: Despite technological advances, the use of homologous blood to prime the cardiopulmonary bypass (CPB) circuits of infants under 10 kg remains common. However, such rapid massive transfusion may increase post-CPB morbidity.
Method: We retrospectively included consecutive patients weighing 2.
Am J Obstet Gynecol
October 2024
Department of Obstetrics and Gynecology, Bordeaux University Hospital, Bordeaux, France. Electronic address:
JAMA Netw Open
October 2024
Department of Neonatal Pediatrics, Intensive Care and Neuropediatrics, Rouen University Hospital, Rouen, France.
Importance: Neurodevelopmental outcomes of very preterm children exposed to tocolytics are not well described.
Objective: To investigate whether tocolysis administered after spontaneous preterm labor is associated with neurodevelopmental outcomes at 5.5 years and to assess whether the type of tocolytic drug is associated with neurodevelopmental outcomes among infants exposed.
Nat Commun
October 2024
The Internal Medicine Department, Groupe Hospitalier Sud, Bordeaux University Hospital, Bordeaux, France.
Chronic histiocytic intervillositis of unknown origin (CHI) is a rare placental disorder associated with adverse pregnancy outcomes, frequent recurrence, and a lack of effective preventive strategies. Recent insights indicate a potential link between CHI-associated inflammatory lesions and the inflammasome pathway, suggesting innovative therapeutic avenues. Here we show a potential role of the inflammasome pathway in CHI through comprehensive transcriptomic analysis of grade 2 or 3 histopathologic CHI samples, paired with placental controls.
View Article and Find Full Text PDFJ Vasc Surg
October 2024
Bordeaux University Hospital Centre, Vascular Surgery Unit, Bordeaux, France.
Acta Neurochir (Wien)
October 2024
Department of Neurosurgery, Bordeaux University Hospital Center, Bordeaux, Cedex, France.
Objectives: Resective surgery is a potential therapeutic option for select patients with intractable focal epilepsy. However, the presence of ictal onset zones within or surrounding highly functional brain areas presents a surgical challenge, leading to poor seizure and functional outcomes. This report describes our experiences with awake mapping-tailored resection of epileptogenic areas involving eloquent cortices and evaluates their feasibility, tolerance, limitations, and significance.
View Article and Find Full Text PDFDig Liver Dis
January 2025
Sorbonne University, Centre for Digestive Endoscopy, Saint-Antoine Hospital, APHP, Paris, France.
Background And Aims: We aimed to evaluate the feasibility, safety and efficacy of endoscopic submucosal dissection for recurrent rectal neoplastic lesions after transanal microsurgery of superficial rectal neoplasms.
Methods: Multicenter retrospective study.
Main Outcomes: recurrence at first endoscopic follow-up, En bloc, R0 and curative resections.
Eur Spine J
December 2024
Spine Surgery Unit, Hospital Universitario La Paz, Madrid, Spain.
Lancet
October 2024
Clinical Trials Unit, London School of Hygiene & Tropical Medicine, London, UK.
Background: Tranexamic acid is a recommended treatment for women with a clinical diagnosis of postpartum haemorrhage, but whether it can prevent bleeding is unclear. We conducted a systematic review and individual patient data (IPD) meta-analysis of randomised controlled trials to assess the effects of tranexamic acid in women giving birth.
Methods: In this systematic review and IPD meta-analysis, we searched the WHO International Clinical Trials Registry Platform from database inception to Aug 4, 2024 for randomised trials that assessed the effects of tranexamic acid in women giving birth.
J Clin Med
October 2024
Department of Internal Medicine, Bordeaux University Hospital, FHU ACRONIM, 33000 Bordeaux, France.
: Prolonged remission on low-dose glucocorticoids (GC) is a main goal in patients with systemic lupus erythematosus (SLE). The aim of this study is to assess whether GC ≤ 5 mg/d increases the risk of damage accrual in patients with SLE in prolonged remission. : Observational study of routine clinical care data of the inception Lupus Cruces-Bordeaux cohort.
View Article and Find Full Text PDFPathology
February 2025
Department of Pathology, Léon Bérard Center, Lyon, France.
BJS Open
September 2024
Hepato-Biliary-Pancreatic Surgery Unit, Digestive Surgery Department, University Hospital, Toulouse, France.
Eur Urol Oncol
October 2024
Département de Médecine Oncologique et Département des Essais Précoces, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Lupus
December 2024
Pediatric Department, Bordeaux University Hospital, Bordeaux, France.
Introduction: Systemic Lupus Erythematosus (SLE) can be diagnosed using the 2012 criteria of the Systemic Lupus International Collaborating Clinics (SLICC) and, more recently, the 2019 criteria of the European League Against Rheumatism/American College of Rheumatology (EULAR/ACR). Hematological involvement is scored differently by these classifications. Our objective was to compare both criteria in a cohort of children with autoimmune cytopenia (AIC)-associated SLE.
View Article and Find Full Text PDFClin Exp Rheumatol
November 2024
Department of Rheumatology, CHU and University of Montpellier, Phymedexp, Université de Montpellier, INSERM, CNRS, Montpellier, France.
Transplantation
August 2024
CNRS UMR 5164 ImmunoConcEpT, University of Bordeaux, Bordeaux, France.
The Banff classification is regularly updated to integrate recent advances in the characterization of kidney allograft rejection, gathering novel diagnostic, prognostic, and theragnostic data into a diagnostic and pathogenesis-based framework. Despite ongoing research on noninvasive biomarkers of kidney rejection, the Banff classification remains, to date, biopsy-centered, primarily relying on a semiquantitative histological scoring system that overall lacks reproducibility and granularity. Besides, the ability of histopathological injuries and transcriptomics analyses from bulk tissue to accurately infer the pathogenesis of rejection is questioned.
View Article and Find Full Text PDF